Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older [Phase 4]

View source ↗

Summary

Describes a multicenter, randomized, double-blind, placebo-controlled Phase IV trial to assess the immunogenicity and safety of a live attenuated herpes zoster …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Live Attenuated Herpes Zoster Vaccine

Snippet

Sponsor: Changchun BCHT Biotechnology Co. | Conditions: Prevention of Herpes Zoster | Phase 4 | Status: NOT_YET_RECRUITING